Page last updated: 2024-08-21

quinazolines and Anti-MuSK Myasthenia Gravis

quinazolines has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fine, HA; Floeter, MK; Iwamoto, FM; Kreisl, TN; Lehky, TJ	1

Other Studies

1 other study(ies) available for quinazolines and Anti-MuSK Myasthenia Gravis

Article	Year
Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome. Neurology, 2011, Jan-18, Volume: 76, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Electromyography; Female; Glioblastoma; Humans; Male; Middle Aged; Myasthenia Gravis; Neuromuscular Diseases; Neuromuscular Junction; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Syndrome	2011

Article

Year

Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.

Neurology, 2011, Jan-18, Volume: 76, Issue:3

Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Electromyography; Female; Glioblastoma; Humans; Male; Middle Aged; Myasthenia Gravis; Neuromuscular Diseases; Neuromuscular Junction; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Syndrome

2011